Tag: clinicaltrials

Jazz Pharmaceuticals provides update on Zepzelca (lurbinectedin) phase 3 trial in second-line small cell lung cancer

Eli Lilly’s Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people...

Akeso’s next-generation HER3 antibody-drug conjugate AK138D1 combined with ivonescimab: first patient enrolled in phase 1b/2 breast cancer study

New MTA-cooperative PRMT5 inhibitor, initiates a phase 1/2 clinical combination study

Izalontamab Brengitecan (Iza-Bren) demonstrates statistically significant and clinically meaningful improvements in overall survival and progression-free survival in patients with triple-negative breast cancer and oesophageal...

New drug applications for Bayer’s FXIa inhibitor accepted by US Food and Drug Administration under priority review and by Japan’s Ministry of Health, Labour...

New analysis shows Tryngolza (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia

BioLineRx and Hemispherian announce new data demonstrating potent anti-tumour effect in Glioblastoma (GBM) across multiple in vivo studies

Orexo announces positive outcome from in vivo study of OX390

Myosin Therapeutics initiates phase 1/2 trial of MT-125 targeting non-muscle myosin II in newly diagnosed glioblastoma